Trials / Completed
CompletedNCT02239484
Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin
An Open-label, Randomized, Multiple-dose Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- Male
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
We investigate the potential pharmacokinetic drug-drug interaction between Tadalafil and Tamsulosin in healthy male volunteers who receive Tadalafil alone, Tamsulosin alone, and both together in a 3 period repeatedly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tadalafil | |
| DRUG | Tamsulosin | |
| DRUG | Tadalafil + Tamsulosin |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2014-09-12
- Last updated
- 2014-09-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02239484. Inclusion in this directory is not an endorsement.